Perioperative antibiotics should be used for placement of implanted central venous ports: A propensity analysis evaluating risk.

In a cohort of cancer patients to receive chemotherapy, 1,091 CVAP were placed in which 59.7% received preoperative intravenous prophylactic antibiotics (PABX). A propensity analysis was done that controlled for 15 demographic, clinical, and procedural variables, that revealed a 58%, reduction in the odds of 14-day CRI (OR=0.42, 95% CI: 0.08-2.24, p=0.31) for those given PABX. Although not statistically significant, the clinical implications of protection provided by PABX should not be overlooked.